While the rise in new, positive Covid-19 cases continue, the S&P 500 (SPX) has hinted at the potential of re-testing the bear-to-new bull market highs. Both of these benchmarks are on the same path and seemingly aiming to befuddle the broader investor community. One proposed reason for the equity market’s defiance of the alarming rise…
I haven’t written an article like this one in the past, so bear with me here folks. This is the type of article that many would characterize as a “public service announcement” or PSA for short. My main consideration for this article are resources. One of the most important concepts about investing that I’ve discovered…
Authored by Chetan Ahya, Chief Economist and Global Head of Economics at Morgan Stanley Will the V Disrupt the V? We received a stark reminder this week that the fight against COVID-19 is not over, as new cases globally thrice reached new highs. Unsurprisingly, the number one question we get from investors is whether this resurgence…
Welcome to another trading week!! In appreciation of all of our Basic Membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly Report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…
Welcome to this week’s State of the Markets with Wayne Nelson and Seth Golden. Please click the following link to review the SOTM video. In this week’s episode, we discuss how we got to this point in the S&P 500’s rally from a bear market into a new bull market. What are the implications from a presidential election year? Is another Cares Act…
Stocks closed higher for a 2nd day in a row, as better than expected manufacturing and services sector data out of Europe helped to support the market. U.S. Markit manufacturing and services data also managed to beat economists’ expectation while New home sales continued to rebound since the April-May lockdown period. The S&P 500 (SPX)…
Markets were lifted higher on Monday despite some of the fears surrounding the rise in new COVID-19 cases over the course of the previous week. The S&P 500 (SPX) rose 20 points or .65% on the day, which actually lagged the small-cap Russell 2000 (RUT) and the tech-heavy Nasdaq (NDX) which both rose just over…
Welcome to another trading week!! In appreciation of all of our Basic Membership level participants and daily readers of finomgroup.com content, we offer the following excerpts from our Weekly Research Report. Our weekly Report is extremely detailed and has proven to help guide investors and traders during all types of market conditions with thoughtful insights and analysis, graphs,…
The background is well known to all. On February 19, the U.S. stock market hit a new all-time high, with the S&P 500 reaching 3,386. Then investors began to price in the novel coronavirus, causing the market to make its fastest trip ever into bear territory, with the S&P 500 down 34% in five weeks…
Article originally published on Financial Times. It was hailed as a breakthrough vaccine for dengue fever, a neglected tropical disease that kills about 20,000 people each year. Dengvaxia, made by Sanofi Pasteur, was being rolled out to more than 800,000 schoolchildren in the Philippines when reports began trickling in of vaccinated children falling seriously ill,…
